Product Information
RIVAROXABAN 2.5 MG TABLET is a generic product labeled by Alembic Pharmaceuticals Inc., priced at $0.7967 per EA under NDC 62332068360. Its NADAC has been published 52 times since Jul 2, 2025.
Strength
2.5 mg/1
Manufacturer
Alembic Pharmaceuticals Inc.NDC
62332068360
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
RIVAROXABANApproval Type
Generic (ANDA)
FDA Application
ANDA210301On Market Since
5/14/2025
Pharmacological Classes
Price Statistics
The NADAC for RIVAROXABAN 2.5 MG TABLET has been published 52 times since Jul 2, 2025, and over the history we have for it it has declined 82.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.7967 per EA |
|---|---|
| All-time high | $4.6446 (Aug 13, 2025) |
| All-time low | $0.7967 (Jun 17, 2026) |
| 52-week high | $4.6446 |
| 52-week low | $0.7967 |
| Median price | $1.4044 |
| Average price | $2.1613 |
| Largest weekly change | -32.4% (Nov 19, 2025) |
| Weeks tracked | 52 |
| Tracking since | Jul 2, 2025 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of RIVAROXABAN 2.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for RIVAROXABAN 2.5 MG TABLET, manufactured by Alembic Pharmaceuticals Inc., is $0.7967 per EA (NDC 62332068360), effective Jun 24, 2026.
How has the price of RIVAROXABAN 2.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for RIVAROXABAN 2.5 MG TABLET has declined 82.5%. It has been tracked across 52 weekly CMS publications since Jul 2, 2025.
What are the highest and lowest recorded NADAC prices for RIVAROXABAN 2.5 MG TABLET?
Since Jul 2, 2025, the NADAC for RIVAROXABAN 2.5 MG TABLET has ranged from a low of $0.7967 (Jun 17, 2026) to a high of $4.6446 (Aug 13, 2025), with a median of $1.4044 per EA.
Are there cheaper alternatives to RIVAROXABAN 2.5 MG TABLET?
2 NADAC-published products share the same active ingredient, strength, and dosage form as RIVAROXABAN 2.5 MG TABLET, but none are currently priced below it.
Who manufactures RIVAROXABAN 2.5 MG TABLET?
RIVAROXABAN 2.5 MG TABLET (NDC 62332068360) is labeled by Alembic Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification